Lewis F. Neville
Chief Executive Officer at Lostam BioPharmaceuticals Ltd.
Lewis F. Neville active positions
| Companies | Position | Start | End |
|---|---|---|---|
Lostam BioPharmaceuticals Ltd.
 Lostam BioPharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lostam BioPharmaceuticals Ltd. engages in the development of protein therapeutics aimed to prevent and treat lethal Gram-negative bacterial infections associated within the hospital setting. The company was founded by Lewis F. Neville on October 15, 2009 and is headquartered in Nof HaGalil, Israel. | Chief Executive Officer | 15/10/2009 | - |
| Chief Tech/Sci/R&D Officer | 15/10/2009 | - | |
| Founder | 15/10/2009 | - |
Career history of Lewis F. Neville
Former positions of Lewis F. Neville
| Companies | Position | Start | End |
|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Corporate Officer/Principal | 01/01/2003 | 01/01/2003 |
Zolex Therapeutics Ltd.
 Zolex Therapeutics Ltd. BiotechnologyHealth Technology Zolex Therapeutics Ltd. operates as a biotechnology company. It develops orally active, small molecular weight antibioticsthat target straphylococcus aureus. The company is headquartered in Tel Aviv, Israel. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - | |
| Sidney Kimmel Medical College | Corporate Officer/Principal | 01/01/1992 | - |
Training of Lewis F. Neville
| University of Leeds | Undergraduate Degree |
| The University of Southampton | Doctorate Degree |
Statistics
International
| Israel | 4 |
| United Kingdom | 3 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Lostam BioPharmaceuticals Ltd.
Lostam BioPharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lostam BioPharmaceuticals Ltd. engages in the development of protein therapeutics aimed to prevent and treat lethal Gram-negative bacterial infections associated within the hospital setting. The company was founded by Lewis F. Neville on October 15, 2009 and is headquartered in Nof HaGalil, Israel. | Health Technology |
Zolex Therapeutics Ltd.
Zolex Therapeutics Ltd. BiotechnologyHealth Technology Zolex Therapeutics Ltd. operates as a biotechnology company. It develops orally active, small molecular weight antibioticsthat target straphylococcus aureus. The company is headquartered in Tel Aviv, Israel. | Health Technology |
- Stock Market
- Insiders
- Lewis F. Neville
- Experience
